Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

New National Center for Molecular Medicine to land in Sweden

next article
02.02.2007

The Swedish Research Council is investing € 8.5 million in a new laboratory for molecular medicine at Umeå University. The laboratory will focus on molecular infectious medicine, and the ultimate objective is for Umeå to become a Swedish node in the European Molecular Biology Laboratory, EMBL.

 

An international panel of experts rewieved the applications, winnowing the applications down to Lund and Umeå as the top two candidates. After a complementary hearing, the involvement and long-term commitment of Umeå University and its close connections with EMBL made the difference.


Swedish research to be strengthened

The aim of this new initiative is to strengthen Swedish research and enhance the dynamics in the field of molecular medicine, partly by promoting the career opportunities for young scientists. Ultimately the goal is for the laboratory to serve as a Swedish node in the European Molecular Biology Laboratory, EMBL. For the coming years the Swedish Research Council has allocated € 8.5 million to be distributed in 2007-2010. Umeå University will contribute some € 10 million.

Infectious medicine in focus

The laboratory now being set up will place its emphasis on the field of molecular infectious medicine. The consortium behind the Umeå Centre for Microbial Research, UCMR, consists of researchers active in the fields of microbiology, molecular biology, chemistry, and physics. The research teams working at the Centre have been successful in the development of vaccines, among other work.

The panel of experts writes: “The potential for scientific renewal in relation to this field is high as well as the potential to build a highly dynamic laboratory. This application comes from one of the very best places to study bacterial pathogenesis in Europe. In summary, this is an outstanding proposal.”

Contact
Lars Börjesson, secretary general, Committee of Research Infrastructures, KFI, phone: +46 (0)8-546 44 109

Lena Gustafsson, deputy director general, VINNOVA, phone: +46 (0)8-473 30 03
Camilla Jakobsson, PR manager, Committee of Research Infrastructures, KFI, phone: +46 (0)8-546 44 336

Camilla Jakobsson | Source: alphagalileo
Further information: www.umu.se

next article

More articles from Health and Medicine:

nachricht Using electrons to treat organic seeds
13.10.2008 | Fraunhofer Institute for Electron Beam and Plasma Technology FEP

nachricht Antioxidants could help Huntington’s Disease sufferers
13.10.2008 | Plataforma SINC

B2B Search

Product / Service
Company / Organisation

Latest News

Brightening the future for optical circuits

13.10.2008 | Physics and Astronomy

Scientists discover bacteria that can cause bone infections

13.10.2008 | Life Sciences

Europe Rallies Behind Nanotechnology To Wean World From Fossil Fuels

13.10.2008 | Ecology, The Environment and Conservation